by Admin | Jan 26, 2019 | News & Opinions
EXELLULA, the new Italian industrial complex entirely dedicated to the development and production of cell and gene therapies, will be a world center of excellence for nonviral technologies. FLYn’ICE is a project for the transport with drones of advanced therapy...
by Admin | Jan 22, 2019 | News & Opinions
Phacilitate Leaders World and World Stem Cell Summit at Hyatt Regency Miami, January 22-25#WSCS2019 and #PLW2019 Daytime seminars, meetings and training Miami, FL, Jan. 22, 2019 (GLOBE NEWSWIRE) — There is only one place in the world to interview and learn from...
by Admin | Jan 22, 2019 | News & Opinions
Glasgow, UK, 22 January 2019: TC BioPharm (TCB), a developer of CAR-T immuno-oncology products, including Gamma Delta T (GDT) cell therapies, today announced it has completed formulation of its first allogeneic GDT cell banks. The T cell banks provide TCB with core...
by Admin | Jan 20, 2019 | News & Opinions
(MENAFN – GetNews) Phacilitate Leaders World, January 22-25, 2019, Miami, Florida Miami, FL – December 27, 2018 – Phacilitate:TALKS , sponsored by Anemocyte, is a brand new stage at this year’s Phacilitate Leaders World , a revolutionary...
by Admin | Jan 20, 2019 | News & Opinions
CALGARY, Alberta, Jan. 17, 2019 (GLOBE NEWSWIRE) — Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to provide the following corporate update on accomplishments and milestones that it has achieved in 2018. The past...